CRT is a clinically proven treatment option for some individuals with heart failure. A CRT device sends small electrical impulses to both lower chambers of the heart to help them beat together in a more synchronized pattern. This may improve the heart’s ability to pump blood and oxygen to your body. 
This report contains market size and forecasts of Cardiac Resynchronization Therapy (CRT) Systems in global, including the following market information:
Global Cardiac Resynchronization Therapy (CRT) Systems Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiac Resynchronization Therapy (CRT) Systems Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiac Resynchronization Therapy (CRT) Systems companies in 2021 (%)
The global Cardiac Resynchronization Therapy (CRT) Systems market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Cardiac Resynchronization Therapy Defibrillators (CRT-Ds) Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiac Resynchronization Therapy (CRT) Systems include Medtronic, Abbott, Boston Scientific, MicroPort Scientific, BIOTRONIK and Medico, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiac Resynchronization Therapy (CRT) Systems manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiac Resynchronization Therapy (CRT) Systems Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy (CRT) Systems Market Segment Percentages, by Type, 2021 (%)
Cardiac Resynchronization Therapy Defibrillators (CRT-Ds)
Cardiac Resynchronization Therapy Pacemakers (CRT-Ps)
Global Cardiac Resynchronization Therapy (CRT) Systems Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy (CRT) Systems Market Segment Percentages, by Application, 2021 (%)
Hospitals
Ambulatory Surgery Centers
Global Cardiac Resynchronization Therapy (CRT) Systems Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiac Resynchronization Therapy (CRT) Systems Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiac Resynchronization Therapy (CRT) Systems revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiac Resynchronization Therapy (CRT) Systems revenues share in global market, 2021 (%)
Key companies Cardiac Resynchronization Therapy (CRT) Systems sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiac Resynchronization Therapy (CRT) Systems sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Abbott
Boston Scientific
MicroPort Scientific
BIOTRONIK
Medico